Neumora Therapeutics, Inc. Net Asset Momentum
Neumora Therapeutics, Inc. net asset momentum. Neumora Therapeutics, Inc. (NMRA) recorded a net asset momentum of -38.8% as of December 2024, with net assets of $287.06 Million USD. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. Explore Neumora Therapeutics, Inc. cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
YoY Momentum
Current Net Assets
Years of Data
Country
Net Asset Momentum of Neumora Therapeutics, Inc. (2019–2024)
Net asset momentum of Neumora Therapeutics, Inc. from 2019 to 2024. This chart tracks Neumora Therapeutics, Inc.'s year-over-year net asset growth across 6 annual reporting periods from 2019 to 2024. The most recent momentum reading is -38.8%, with net assets of $287.06 Million USD as of December 2024. See NMRA book value for net asset value and shareholders' equity analysis.
Neumora Therapeutics, Inc. Net Asset Momentum by Year (2019–2024)
Neumora Therapeutics, Inc. net asset momentum by year from 2019 to 2024. The table below shows the complete annual net asset history for Neumora Therapeutics, Inc. from 2019 to 2024, covering 6 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and overall valuation, see NMRA market cap overview.
| Year | Net Assets (USD) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2024 | $287.06 Million | $316.97 Million | $29.91 Million | ▼ -38.8% |
| 2023 | $469.08 Million | $496.19 Million | $27.12 Million | ▲ +205.0% |
| 2022 | $-446.85 Million | $426.23 Million | $873.08 Million | ▼ -37.4% |
| 2021 | $-325.22 Million | $429.30 Million | $754.52 Million | ▼ -244.6% |
| 2020 | $-94.38 Million | $197.95 Million | $292.33 Million | ▼ -449347.6% |
| 2019 | $-21.00K | $0.00 | $21.00K | — |